SHL Telemedicine Ltd.

Symbol: SHLT

NASDAQ

4.0945

USD

Market price today

  • -28.2514

    P/E Ratio

  • 0.4440

    PEG Ratio

  • 67.11M

    MRK Cap

  • 0.00%

    DIV Yield

SHL Telemedicine Ltd. (SHLT) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.44%

Operating Profit Margin

-0.14%

Net Profit Margin

-0.04%

Return on Assets

-0.02%

Return on Equity

-0.03%

Return on Capital Employed

-0.07%

Company general description and statistics

Sector: Healthcare
Industry: Medical - Healthcare Information Services
CEO:Mr. Erez Nachtomy
Full-time employees:402
City:Tel Aviv
Address:Ashdar Building
IPO:2023-04-03
CIK:0001166834

SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. The company offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter device; Cardio'B, a portable device to transmit a 12-lead ECG; and Cardio Beeper 12/12, a hand-held ECG transmitter device for personal use that transmits a full ECG reading to the monitoring center. It also provides central communication module, a telecommunication device that transmits medical data to its telemedicine centers from various medical monitoring devices; TeleWeight, a trans-telephonic weight monitoring device for personal use; TelePress, a remote blood pressure monitoring device for personal use; TeleBreather, a remote electronic handheld device to test the working of lungs; and TelePulse Oximeter, an electronic handheld diagnostic device to measure the saturation level of oxygen in blood, as well as pulse rate. The company offers its telemedicine services and devices to subscribers using telephonic and internet communication technology. It serves patients, health insurance companies, hospitals, clinics, physicians, and other health care providers. The company has a collaboration agreement with Mayo Clinic to evaluate the incidence of emergency department visits, re-hospitalizations, and major adverse cardiovascular events over a period of 90 days after first hospitalization for a heart attack for patients using SmartHeart FDA approved 12 lead ECG; and collaboration agreement with the Hebrew University of Jerusalem and the Hadassah Medical Center to develop an artificial intelligence tool for predicting future life-threatening cardiac events based on 12 Lead ECG monitoring. SHL Telemedicine Ltd. was founded in 1987 and is headquartered in Tel Aviv, Israel.

General Outlook

When we look at how much money they make before expenses, they keep 0.439% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -0.136%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -0.041%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -0.019% return, is a testament to SHL Telemedicine Ltd.'s adeptness in optimizing resource deployment. SHL Telemedicine Ltd.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -0.035%. Furthermore, the proficiency of SHL Telemedicine Ltd. in capital utilization is underscored by a remarkable -0.074% return on capital employed.

Stock Prices

SHL Telemedicine Ltd.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $4.7, while its low point bottomed out at $4.62. This variance in figures offers investors a lucid insight into the roller-coaster ride that is SHL Telemedicine Ltd.'s stock market.

Liquidity Ratios

Analyzing SHLT liquidity ratios reveals its financial health of the firm. The current ratio of 279.55% gauges short-term asset coverage for liabilities. The quick ratio (254.39%) assesses immediate liquidity, while the cash ratio (65.70%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio279.55%
Quick Ratio254.39%
Cash Ratio65.70%

Profitability Ratios

SHLT profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -0.73% underscores its earnings before tax deductions. The effective tax rate stands at -373.50%, revealing its tax efficiency. The net income per EBT, 556.89%, and the EBT per EBIT, 5.36%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of -13.56%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin-0.73%
Effective Tax Rate-373.50%
Net Income per EBT556.89%
EBT per EBIT5.36%
EBIT per Revenue-13.56%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 2.80, it details the span from stock purchase to revenue. The 3 days it takes to settle debts showcases its creditor relations. Meanwhile, a 1 cash conversion cycle and 516.77% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

cards.indicatorcards.value
Days of Sales Outstanding254
Days of Inventory Outstanding46
Operating Cycle116.52
Days of Payables Outstanding42
Cash Conversion Cycle74
Receivables Turnover5.17
Payables Turnover8.66
Inventory Turnover7.95
Fixed Asset Turnover3.65
Asset Turnover0.47

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -0.34, and free cash flow per share, -0.74, depict cash generation on a per-share basis. The cash per share value, 1.86, showcases liquidity position. Lastly, the operating cash flow sales ratio, -0.09, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share-0.34
Free Cash Flow per Share-0.74
Cash per Share1.86
Operating Cash Flow Sales Ratio-0.09
Free Cash Flow to Operating Cash Flow Ratio2.21
Cash Flow Coverage Ratio-0.34
Short Term Coverage Ratio-1.18
Capital Expenditure Coverage Ratio-0.83
Dividend Paid and Capex Coverage Ratio-0.83

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 13.20%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.21, we discern the balance between debt and equity financing. The long-term debt to capitalization, 12.90%, and total debt to capitalization, 17.14%, ratios shed light on its capital structure. An interest coverage of -2.94 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio13.20%
Debt Equity Ratio0.21
Long Term Debt to Capitalization12.90%
Total Debt to Capitalization17.14%
Interest Coverage-2.94
Cash Flow to Debt Ratio-0.34
Company Equity Multiplier1.57

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 4.06, provides a glimpse into top-line earnings distributed across each share. Net income per share, -0.01, reflects the portion of profit attributed to each share. The book value per share, 3.83, represents the net asset value distributed per share, while the tangible book value per share, 0.35, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share4.06
Net Income Per Share-0.01
Book Value Per Share3.83
Tangible Book Value Per Share0.35
Shareholders Equity Per Share3.83
Interest Debt Per Share1.91
Capex Per Share-0.47

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 18.99%, indicates top-line expansion, while the gross profit growth, 10.56%, reveals profitability trends. EBIT growth, -939.44%, and operating income growth, -939.44%, offer insights into operational profitability progression. The net income growth, 99.46%, showcases bottom-line expansion, and the EPS growth, 99.48%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth18.99%
Gross Profit Growth10.56%
EBIT Growth-939.44%
Operating Income Growth-939.44%
Net Income Growth99.46%
EPS Growth99.48%
EPS Diluted Growth99.48%
Weighted Average Shares Growth3.53%
Weighted Average Shares Diluted Growth3.53%
Operating Cash Flow Growth-139.46%
Free Cash Flow Growth-127.04%
10-Year Revenue Growth per Share57.85%
5-Year Revenue Growth per Share13.87%
3-Year Revenue Growth per Share1.74%
10-Year Operating CF Growth per Share-103.24%
5-Year Operating CF Growth per Share-100.44%
3-Year Operating CF Growth per Share-100.49%
10-Year Net Income Growth per Share99.25%
5-Year Net Income Growth per Share-102.28%
3-Year Net Income Growth per Share-100.96%
10-Year Shareholders Equity Growth per Share-34.19%
5-Year Shareholders Equity Growth per Share37.54%
3-Year Shareholders Equity Growth per Share15.76%
3-Year Dividend per Share Growth per Share-100.00%
Receivables Growth1.95%
Inventory Growth-7.69%
Asset Growth-14.51%
Book Value per Share Growth-5.39%
Debt Growth-17.72%
R&D Expense Growth978.89%
SGA Expenses Growth260.80%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 234,644,910, captures the company's total value, considering both debt and equity. Income quality, -0.34, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.35, gauges operational efficiency, while the research and development to revenue, 6.42%, highlights investment in innovation. The ratio of intangibles to total assets, 48.90%, indicates the value of non-physical assets, and capex to operating cash flow, 9457.53%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value234,644,910
Income Quality-0.34
Sales General and Administrative to Revenue0.35
Research and Development to Revenue6.42%
Intangibles to Total Assets48.90%
Capex to Operating Cash Flow9457.53%
Capex to Revenue-11.70%
Capex to Depreciation-96.78%
Stock-Based Compensation to Revenue2.98%
Graham Number0.67
Return on Tangible Assets-0.13%
Graham Net Net-1.65
Working Capital14,463,000
Tangible Asset Value5,119,000
Net Current Asset Value-19,206,000
Average Receivables9,098,000
Average Payables3,321,000
Average Inventory4,040,500
Days Sales Outstanding57
Days Payables Outstanding43
Days of Inventory On Hand45
ROIC-0.90%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 0.85, and the price to book ratio, 0.85, reflect the market's valuation relative to the company's book value. The price to sales ratio, 1.18, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, -5.71, and price to operating cash flows, -12.21, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio0.85
Price to Book Ratio0.85
Price to Sales Ratio1.18
Price Cash Flow Ratio-12.21
Price Earnings to Growth Ratio0.44
Enterprise Value Multiple-104.45
Price Fair Value0.85
Price to Operating Cash Flow Ratio-12.21
Price to Free Cash Flows Ratio-5.71
Price to Tangible Book Ratio3.81
Enterprise Value to Sales3.98
Enterprise Value Over EBITDA109.85
EV to Operating Cash Flow-3214.31
Earnings Yield-0.04%
Free Cash Flow Yield-3.29%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of SHL Telemedicine Ltd. (SHLT) on the NASDAQ in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -28.251 in 2024.

What is the ticker symbol of SHL Telemedicine Ltd. stock?

The ticker symbol of SHL Telemedicine Ltd. stock is SHLT.

What is company IPO date?

IPO date of SHL Telemedicine Ltd. is 2023-04-03.

What is company current share price?

Current share price is 4.095 USD.

What is stock market cap today?

The market cap of stock today is 67114702.000.

What is PEG ratio in 2024?

The current 0.444 is 0.444 in 2024.

What is the number of employees in 2024?

In 2024 the company has 402.